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I Introduction 
 
Anesthesia allows practicing surgical or diagnostic acts if their profits for the patient are 
superior to anesthesia inherent risks. Anesthesia is based on combinations of pharmacological 
drugs administrated to the patient to induce sleep (hypnosis), avoid pain (analgesia) and to 
inhibit reflex or automatic muscular tonuses. The anesthetic agents alter the normal 
functioning of one or several nervous systems: the peripheral, the central and the autonomic 
nervous system. The regulation mechanisms, driven by the autonomic nervous system, can 
then be interrupted leading to important systemic functions disturbances, which can be 
amplified by the intervention (as the bleeding and the hypovolemia, …), by the status of the 
patient and by the overdosing in the administered products.  
 
One of the main tasks of the anesthetist is to maintain an adequate state of anesthesia by 
balancing the effects of the hypnotic, the analgesic and the muscular relaxants. If objective 
evaluations of the muscle relaxation is simple (measure of muscle contraction induced by an 
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electrical stimulation), the "depth" of anesthesia, in terms of hypnosis and analgesia, is more 
difficult to define and to quantify. It depends on the used substances, their dosage and their 
interaction, and on the patient.  
In practice, it is indirectly assessed using physiological variables (heart rate, blood 
pressure…) and clinical signs (perspiration, eyes position, limbs movements…), which 
highlight the depression of certain activities of nervous system. Although the brain is so far 
the main target of the administered products, the analysis of the electrical activity of the brain 
is rare even for general anesthesia.  
 
II Anesthesia in France 
 
The last inquiry on the practice of the anesthesia in France goes back up to 1996 and its 
results were published in 1998 (1). It estimated that 8 millions of anesthesia are practiced each 
year. Reported to the French population, it corresponds to an annual rate of 13.5 anesthesia 
for 100 inhabitants. This rate varies according to the sex and to the age. From 10 years, rates 
increase with the age of patients. They are higher, for the women between 15 and 54 years, 
and for the men before 15 years and after 54 years.  
 
A third of anesthesia is practiced on patients 60 years old and more, 55 % for patients from 15 
to 59 years old and 12 % for children less than 15 years. In 55 % of cases, the anesthesia is 
practiced on women. 88 % of anesthesia concern patients of class ASA11 or 2, where 56 % 
are women; and the remaining 12 % of anesthesia concern patients of the classes ASA3 to 5, 
                                                 
1 ASA (American Society of Anesthesiologists) risk/complication classifications 
1 Healthy Patient, 
2 Patient with mild, controlled, functionally nonlimiting systemic disease, 
3 Patient with severe or poorly controlled systemic disease that is functionally limiting, 
4 Patient with severe systemic disease that is a constant threat to life, 
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where 59 % are men. The 90 % of patients of class ASA3 to 5 are patients of more than 45 
year old.  
 
Between 1980 and 1996, the increase of the number of anesthesia is globally 120 %. This 
increase is particularly noted in three categories of population:  
1) children less than 5 years where the anesthesia in ENT (Ear, Nose, Throat) represents 
70 % of the increase,  
2) women from 20 to 39 years where obstetric anesthesia represents 63 % of the increase,  
3) patients more than 60 years old. Digestive endoscopy, orthopedics and ophthalmology 
represent 61 % of the increase observed in this age range.  
 
The general anesthesia is dominant with more than 77 % of the practiced acts. For a number 
of anesthesia estimated to 6,7 millions, a unique anesthetic agent is administered, by 
intravenous injection or inhalation, with or without association of a local anesthesia. It 
concerns, in 59 %, the surgery and more particularly the orthopedic, digestive field and ENT 
(respectively 26 %, 13 % and 12 % of the entire general anesthesia). In 72 % of the single 
general anesthesia, 3 products at least are used and only 3 % contain just one (hypnotic) drug.  
 
The risk associated to the anesthesia within the context of the operating room risk is rather 
weak but remains difficult to exactly estimate (2). Deaths Attributable to the anesthesia 
represent 2 to 10 % of the entire deaths reported in the operating roam. The INSERM inquiry 
of 1983 (3) establishes this risk to 1/12000 in France. It shows, based on 198103 anesthesia 
practiced in France from 1978 to 1982, that the risks of the most critical accidents and of 
death are maximum at the recovery phase (due to respiratory depression). The decree n° 94-
                                                                                                                                                        
5 Moribund patient no expected to survive 24 hours with or without surgery. 
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1050 of December 5, 1994 concerning the safety of anesthesia requires, for every scheduled 
anesthesia, a medical consultation with an anesthetist and the checking of a list of materials 
and devices. The purpose is to practice the anesthesia according to an established protocol, 
which includes the patient state and its inherent risks.  
The risk of anesthesia is composed by predictable and unpredictable accidents. The cardio-
circulatory and respiratory accidents are the predictable ones. They may be circulatory arrest 
often due to hypovolemia during induction, to respiratory depression in the recovery phase, to 
inhalation of the gastric contents (patient not on an empty stomach) particularly in emergency, 
and to complications related to the tracheal intubation.  
Unpredictable accidents could be connected to the dysfunction of the used material (mixer of 
gas, manometer …), to errors of manipulation, to the non checking of certain devices before 
use (notably in emergent anesthesia), to an anaphylactic shock to anesthetics or to unknown 
disease revealed with the anesthesia, and to a surgical discovery. Explosion or electrical 
breakdown are very rare accidents, malign hyperthermia is an exceptional accident.  
 
The previous paragraphs underline the importance of the anesthesia and its utility in term of 
health care. The evolution over the last ten years has allowed patients at the extreme ages to 
benefit from the surgery.  
 
III Monitoring in general anesthesia 
 
Anesthetics obey to the pharmacokinetic and pharmacodynamic laws and each product has its 
own characteristics. They are only effective starting from a minimal concentration in the 
nervous tissues or in the bloody plasma. As their effects decrease in the time in an exponential 
way, they must be administered continuously or periodically. The required dose for a given 
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effect is not the same for all the patients. Each product is administered according to a specific 
curve, which indicates the required quantity to efficiently anaesthetize (insensitivity to 
incision) 50 % of patients (the Minimal Alveolar Concentration - MAC for the case of 
halogenated gasses). Therefore the injected intravenous dose and/or the concentration of 
inhaled gas can be approximately adapted to a given patient (too deep or too light anesthesia)  
 
III.1 Clinical practice 
 
The decree n° 94-1050 of December 5, 1994 concerning the safety of anesthesia requires the 
monitoring of the cardiovascular and the respiratory systems. In clinical routine, the ECG 
signal and the heart rate are monitored as well as the blood pressure obtained invasively or not 
(according to the status of the patient). The amount of inspired oxygen is controlled as well as 
the oxygen blood saturation. Most of the general anesthesias include a tracheal intubation and 
artificial ventilation to avoid the risks of respiratory depression. The expired concentration of 
carbon dioxide and the anesthetic gas, if the later is used, are then monitored.  
 
These parameters are relevant for the follow-up of the clinical status of the patient but are 
relatively poor as regard to the evaluation of the depth of anesthesia. There is no objective 
scale between a " too light " and a " too deep " anesthesia. The consequence of a too light 
anesthesia maybe at least memorization of what happened in the operating room, or at most 
the occurrence of a myocardial ischemia for a coronary patient. The consequence of a too 
deep anesthesia could be the necessity of a hemodynamic assistance with vasoconstrictor 
agents to maintain a normal blood pressure, a normal cardiac output and a respiratory 
assistance post-operatively or a secondary respiratory depression due to an overdosing in 
anesthetic agents.  
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 At present, the assessment of the depth of anesthesia is essentially based on clinical signs to 
evaluate a reaction to a too painful stimulus and/or to a too light anesthesia for a given 
surgical act: movement of the patient, if muscle relaxants were not used, essentially an 
increase of the heart rate and of the blood pressure. Note that most of anesthetic agents have 
some side effects that could interfere with hemodynamic signs. Furthermore, in certain cases, 
these clinical signs are not available any more (cardiac arrest in heart surgery i.e. 
cardiopulmonary bypass).  
 
III.2 Clinical research 
 
Anesthesia monitoring is subject to numerous researches and stimulates the interest of big 
industrial groups. The investigations go from the simple analysis of a single signal, for the 
production of an alarm, to the extraction and the combination of several parameters for the 
automatic control of a closed loop system. In addition to the previously mentioned signals, the 
reported methods are based upon a continuous EEG recordings or Evoked Potential (EP) by 
sensorial stimulation, and on EMG signals.  
 
III.2.1 EEG in anesthesia 
 
The absorption of anesthetic agents, in variable doses, modifies in a more or less pronounced 
way, frequency and mean amplitude of the EEG (4). For the most part of volatile and 
intravenous hypnotic drugs as the propofol, the benzodiazepines and the barbiturates, the 
inspection of the EEG reveals morphological changes. In low doses, the mean frequency of 
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the EEG increases (activation) mainly the β band (> 13Hz) and its mean power decreases in 
the α band (8-13Hz). By increasing the dose, the mean frequency of the signal decrease and 
its amplitude increases and θ (4-7 Hz) or δ (< 4 Hz) waves appear. For high doses of certain 
agents, the EEG exhibits a particular pattern called Burst-Suppression, which is a succession 
of periods of silence or isoelectric (amplitude < 5μ V) and of discharge, and finally becomes 
flat (5). The effect of certain classes of anesthetic agents on the EEG moves away from this 
description. For example, the opioids slow down the EEG without the initial phase of 
activation whereas benzodiazepines do not lead to burst-suppression phenomenon. Generally, 
two different agents produce different morphological modifications on the EEG and their 
effects are not cumulative. Furthermore, these morphological figures are not specific to the 
anesthesia. Indeed, a severe cortical deterioration can induce similar EEG modifications as 
those observed under the influence of an anesthetic (6) (7). Therefore the inspection of the 
EEG signal for interpretation and diagnostic, during an anesthesia, is not easy and requires a 
meticulous learning.  
 
The main goal of processing EEG signals is to derive, reliable and reproducible, quantitative 
parameters which correlate with the clinical status of the patient (physiological and 
pharmacological).  
Artifacts, which often corrupt the EEG, are from different origins. They could be related to 
biological sources (i.e. the electromyogram and/or the electrocardiogram, the eye 
movements), to the acquisition devices (i.e. saturation of amplifiers induced by movements of 
electrodes, power line interference), or furthermore to the particular conditions of recording 
(electro-surgical instruments, diathermy knife, pump, …). To reduce these artifacts, temporal 
(as filtering) or spectral methods (estimation of the spectral contents by FFT or AR modeling) 
but also approaches based on heuristic considerations (correlation among sensors, locations 
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on privileged channels, duration of activities, …) are used. Nevertheless, the portions of 
signal moderately or strongly corrupted, where characteristic events may be present, are 
excluded from the analysis.  
 
On the other portions of EEG, different signal processing techniques were used. Temporal 
methods derive parameters related directly to the amplitude or to the distribution of the EEG. 
Mean power on a sliding window was one of the first monitors extracted from the EEG and 
correlated to the administered anesthetic dose (8). Works conducted in (9, 10) evidenced a 
relation between the frequency of zero crossings of the EEG and the concentrations of 
anesthetic agents but no significant correlation were established with the awakening. The 
zero-crossing frequency of the EEG is also correlated with the ability of a patient to execute a 
simple command (11). However, the authors conclude that this parameter presents a high 
variability, which limits its use. The measure of the relative duration of EEG suppression with 
regard to the observation duration (i.e. Burst-Suppression Ratio) was proposed in (5) to 
monitor the therapeutic coma using barbiturates. This parameter was also used to 
automatically control a closed loop of anesthetic agent injection (12).  
 
Frequency domain methods were also explored. The basic ingredient is the spectrum of the 
EEG signal obtained by the Fast Fourier Transform (in a sliding window or not) or by a 
parametric method (AR or ARMA). The use of the power spectral density was suggested in 
(8, 13). However, each anesthetic agent has its own characteristic effects on the EEG 
spectrum as pointed out in (14-17). To overcome this limitation, the works based on spectral 
analysis were conducted on variables or descriptors derived from the entire spectrum. The 
classically used parameters include: 1) dominant power frequency (DF). 2) Median power 
frequency (MF). 3) 90 and 95 % spectral edge frequency (SEF) -frequency below which 90 or 
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95 % of the total power of the signal is concentrated (18). 4) Power (relative to the total power 
or not) in particular frequency bands of the EEG.  
 
On animal, SEF variation follows the change of the concentration of halothane and enflurane 
(18). These spectral characteristics exhibit important changes at the transition from the state 
of unconsciousness to recovery (19-21). Unfortunately, such parameters may vary 
significantly, in an incoherent manner, during anesthesia (22, 23) and do not allow predicting 
the patient movements in reaction to incision (24, 25). EEG power distribution over particular 
frequency bands (β, α, θ and δ) has also been considered to characterize the effects of 
anesthesia on EEG signal (21, 26-29). It comes out that, once again, different anesthetics can 
produce totally different energy distributions. Spectral parameters and powers in the various 
frequency bands of the EEG were simultaneously used in particular works (30-32). The 
combination of these descriptors, based on linear and nonlinear procedures, seems to be 
correlated with anesthetic agent dosages. The linear approaches are highly variable and non-
linear ones require a larger validation.  
 
This class of methods relies on the first order statistics of the EEG signal. The use of methods 
based on higher order spectral analysis, more particularly the bispectrum analysis, on the EEG 
for the study of the states of awareness on rats, was considered in (33). A company (Aspect 
Medical System) proposed a monitor of the hypnotic effect of the anesthetic agents noted BIS. 
It is a combination of variables issued from temporal, spectral and bispectral domains. The 
temporal variable is related to the phenomenon of suppression of brain activity. The spectral 
one is derived from the spectral representation by means of the logarithm of the ratio of 
powers in two frequency bands (30-47 and 11-20 Hz). The last variable is the logarithm of the 
ratio of cumulated values of the bispectrum over two squares (0.5,0.5 - 47,47 and 40,40 - 47-
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47 Hz). Each of these variables is averaged on epochs of one-minute duration (34). This new 
monitor of depth of anesthesia has been the subject of many evaluation studies (35-39). For 
patient movements prediction after incision, the BIS provides better results compared with 
spectral parameters. However the prediction of absence of movement is less accurate and the 
interpretation of its values is dependent on the technique and the anesthetic agents used. For 
patients correctly analgezed (40), or anaesthetized only with the sevoflurane (41), neither the 
BIS nor the spectral parameters allow predicting reactions to incision. Other works showed 
that the BIS allows predicting the loss of consciousness and that it is correlated to the patient 
ability to execute simple commands (42) and that its use for the administration of certain 
anesthetic products allows reducing the recovery period duration in the ambulatory anesthesia 
(43). A recent study showed that hypnosis could be reached using the nitrous oxide without 
changes in the BIS monitor (44). The use of neural networks and integrator with fuzzy logic 
membership rules, based on EEG bispectrum analysis (not the BIS), hemodynamical 
parameters and the MAC, allows estimating the depth of anesthesia and the prediction of 
movements on animal (45).  
 
III.2.2 Evoked potential in anesthesia 
 
The EEG is modified when a sensory stimulation occurs. With adequate techniques, it is 
possible to collect these modifications called evoked potential. It is a succession of waves for 
which the latency of appearance measures the required time for a sensory stimulation to be 
collected by a receiver, and transmitted to the brain. The amplitude of the response depends 
on the number of neurons activated by the stimulation. The first activated generators at the 
cerebral cortex level are in the brain area, which is specific to the used sensory modality 
(occipital region for the vision, temporal for the hearing and parietal for the touch). Other 
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regions of the brain are activated later, depending on the type of processing that stimulation 
undergoes. Evoked potentials are generally classified according to the nature of stimuli. One 
distinguishes so Visual Evoked Potentials (VEP) : they are obtained following a flash stimuli. 
Somatosensory Evoked Potentials (SEP) are provoked by means of a small electric shock 
applied to a peripheral nerve. Auditory Evoked Potentials: they are induced by means of 
emitted brief sounds (e.g.: clicks) stimulating the cochlea of the internal ear.  
 
Two components can be distinguished in evoked potentials. The exogenous components 
correspond to the common part of the processing which any stimulation has to undergo. These 
components are usually measured in the laboratories of neurological functional investigation. 
They include waves, generated in the brainstem (Brainstem Evoked Potential) and appearing 
in the 10 ms following the stimulation, and waves arising between 10 and 100 ms (Middle 
Latency Evoked Potential). The endogenous components depend on the attitude of the patient 
regarding the stimulation and particularly his attention. They appear especially after a time 
delay of 100 ms following the stimulation.  
 
Studies of the anesthesia effects on evoked potential concern mainly exogenous components 
of Auditory Evoked Potentials (AEP) (46). The intravenous agents such as the secobarbital, 
the althesin, the etomidate and propofol produce changes related to the absorbed dose: the 
latency of the MLAEP increases and its amplitude decreases while the BAEP remains 
approximately unchanged (47-49). Effects of opioid agents are particular: the latency of the 
MLAEP is increased but this modification does not seem to be correlated to the administered 
dose, and the amplitude is not affected (50), which seems coherent with the fact that opioid 
mainly possesses analgesic properties (51). The volatile anesthetic agents, such as halothane, 
enflurane and isoflurane, also produce concentration dependant changes on the latency of 
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BAEP and MLAEP, and the amplitude of this later decreases (52-55). Other studies showed 
that the MLAEP can predict movement during the tracheal intubation (56) and recovery (57, 
58) and a monitor based on the MLEAP, noted AEP index, has been proposed (59). 
Comparative studies conducted between the BIS index, the AEP index and the spectral 
parameters (56, 60, 61) show that the AEP allows better distinguishing the transition from 
unconsciousness to consciousness and predicting patient movement during intubation. Recent 
works try to exploit the MLAEP to estimate and to control the depth of anesthesia. A subset 
of a wavelets decomposition of the MLAEP is used as the input of a neural network which 
estimates depth of anesthesia and, by means of decision rules based on fuzzy logic, control the 
propofol dosing (62).  
 
III.2.3 ECG in anesthesia 
 
In contrast with the EEG, the ECG signal is routinely monitored in general anesthesia. The 
heart rate variability is caused by the fluctuation in sympatic and parasympatic tones and 
reflects the influence of autonomic nervous system on the functioning of the cardiac muscle. 
Briefly, sympatic stimulation increases the heart frequency (chronotropic effect) and 
myocardial contractility (inotropic effect), causes a vasoconstriction of the peripheral vessels, 
increases the afterload, increases the myocardial excitability (bathmothropic effect) and 
decreases the delays of conduction (dromotropic effect). Parasympathic stimulation is having 
approximately inverse effects. Sympatic tone stimulates simultaneously atrias and ventricles 
and parasympatic acts mainly on atrias.  
 
Spectral analysis allows evaluating the variability of heart rate and provides an estimation of 
the influence of each tone (63, 64). The high frequency (HF) components correspond to the 
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parasympatic activity modulated by breathing (respiratory arrhythmia). Low and very low 
frequencies (LF and VLF) are influenced by both tones. The general anesthesia depresses the 
variability of heart rate (65-69) and inhibits its adaptability to blood pressure changes (70). 
Works conducted in (71) showed that the amplitude of the respiratory arrhythmia decreases in 
presence of isoflurane and nitrous oxygen and that the spectral components of heart rate 
increase in the recovery phase. The effect of volatile agents in heart rate was also considered 
in (66): total power and powers in HF, LF and VLF bands decrease during the anesthesia and 
the depression in the LF band is more pronounced without any significant difference between 
the halothane and the isoflurane. The effects of the propofol in heart rate are reported in (72) : 
variability in high frequencies is more depressed than in low frequencies and the shape of 
heart rate spectrum evolves with the depth of anesthesia. Such significant variations on the 
spectral components of heart rate were also described in (69) during a general anesthesia 
associating several volatile and intravenous anesthetic agents. Other works showed that, under 
general anesthesia by enflurane or isoflurane, heart rate variability is correlated to the 
occurrence of EEG burst-suppression patterns (73, 74). Heart rate increases during the burst 
and decreases at the onset of the suppression. However, this correlation is lost in the presence 
of atropine (75). A recent comparative study between the BIS index, the spectral parameters 
of the EEG and parameters derived from the heart rate (variances on epochs of 10 and 20 
seconds) concluded that the BIS index offers a better differentiation between unconscious and 
conscious patients (76).  
 
III.2.4 Other biomedical signals in anesthesia 
 
The frontal electromyogram allows reflecting the psychological stress of the patient (9). 
Studies showed that the amplitude of this signal is correlated to the movements of the patient 
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and to the transitions from the unconsciousness to the consciousness state and conversely, 
without however any possibility to predict the occurrence of transitions (77, 78). Comparison 
led in (78) between the EMG, the BIS index and the spectral parameters concludes that BIS is 
the best monitor of the occurrence of transitions. Unfortunately, results are not stable (big 
variability among individuals). The spontaneous contractility of the esophagus is modulated 
by autonomic nervous system. It was also proposed as an indicator of the depth of anesthesia. 
Contractility reduces when the dose of halothane, isoflurane or propofole increases (79, 80). 
However, these results were not confirmed and the technique is sensitive to the sensor 
location and to the administration of vagotonics or of vagolytics.  
 
III.3 Discussion  
 
This review concerning the monitoring of anesthesia brings to several observations. 1) There 
is an important volume of publications dedicated to the subject. 2) The main motivation is the 
search for a global monitor capable to summarize all the information (the BIS index is the 
best example). 3) There is a lack of actual conclusions that may lead to efficient measures and 
real means of decision and/or control. 4) The exploitation of the advanced data processing 
methods is recent.  
 
Most of these works are of experimental and clinical nature and concern variations of use and 
associations of anesthetics or analgesics drugs. The multiplicity of agents and clinical 
protocols widens then the combinatorial of situations. Usually, the extracted parameters from 
the various signals are very global (dominant frequency, average frequency in EEG,…). They 
might be insufficient to express short-time spectral reorganizations or complex temporal 
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relations. Only few methodological works were dedicated to the anesthesia monitoring which 
underlines the difficulty of such a problem.  
 
More fundamentally, this review points out the limits of approaches only based on isolated 
observations and so without strong links with the underlying physiological and 
neurophysiological processes. Deep modeling of important systemic functions and regulating 
mechanisms involved in the anesthesia (as the cardiovascular, the autonomic and the central 
nervous systems), and their interactions with drugs (hypnotics and analgesics), can lead to a 
better understanding of the anesthetic-induced changes and so the global behaviors of the 
systems. Nevertheless modeling approaches are confronted with some fundamental questions 
as their identification, the choice of the description level, the measure of relative quality 
between models, and the evaluation of performances (81). With the help of signal processing 
techniques and data fusion methods (82-84), such a modeling can bring significant progresses 
in the monitoring of anesthesia's agents.  
 
Works dedicated to these issues concerned the mono-variable hemodynamics control (blood 
pressure) (85), the bi-variables hemodynamics control (blood pressure and cardiac output) 
(86, 87) or the control of propofol concentration (88). Most of the modeling techniques are 
based on compartmental approach (89, 90). From the theoretical point of view, these models 
are well known and their limits are clearly identified. It is their physiological foundation and 
their multisystem-multivariable articulation that might be questionable. In deed, It is 
important to note that controversies persist on the underlying mechanisms of the anesthesia 
(91, 92). In spite of numerous works concerning the effect of opioids on the respiratory 
depression, it is only recently that a first pharmacokinetic-pharmacodynamic model was 
proposed (93). Likewise, the capacity of global physiological models (integrating functions 
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driving the distribution and the elimination of opioids) to predict their concentrations is far 
from being guaranteed (94). By changing the level of description from macroscopic to 
microscopic, a significant gain can be expected as demonstrated in other biomedical areas (95, 
96) and which, for example, could explain the reversible changes observed in different 
modalities of electroencephalography during anesthesia (97). However, only very few 
research are reported on the effect of anesthetics on the mechanism of the potassium currents 
(ionic channels) (91).  
 
Models can be used for simulation, i.e. as generators of physiologically based observations 
and scenarios. In this case they allow, a better understanding of dose-effect relations, 
identifying the determinants of observed variabilities, and so to individualize and to optimize 
clinical protocols. A more ambitious application consists of identifying on the basis of 
measured signals, a physiological model for which parameters or structures are dynamically 
configurable to allow integrating the patient status. Such a system would directly open the 
way to an efficient and reliable closed-loop control of both the hypnotic and the analgesic 
parts of an anesthesia.  
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